$IBB Recent Headlines More records for U.S. stocks as

New Post Public Reply Private Reply Replies (0) Message Board

Dec 31, 2014 at 11:50 AM

$IBB Recent Headlines

More records for U.S. stocks as Dow tops 18,000 for first time 4:05 p.m. Dec. 23, 2014 - Anora Mahmudova
Small caps rise within view of uncharted territory 10:26 a.m. Dec. 22, 2014 - Michael Ashbaugh
S&P 500 spikes from major support 11:32 a.m. Dec. 11, 2014 - Michael Ashbaugh
Charting the latest slow-motion breakout attempt 11:22 a.m. Dec. 4, 2014 - Michael Ashbaugh
Strong bull trend reaches uncharted territory 11:51 a.m. Nov. 25, 2014 - Michael Ashbaugh
Strong bull trend reaches uncharted territory 11:29 a.m. Nov. 25, 2014 - Michael Ashbaugh
The trouble with fundamentals 1:38 p.m. Nov. 11, 2014 - The Trading Deck
Charting the S&P 500’s slow-motion breakout 11:00 a.m. Nov. 7, 2014 - Michael Ashbaugh
Amgen's stock drops after trial misses secondary endpoint 9:20 a.m. Nov. 4, 2014 - Tomi Kilgore
S&P, Nasdaq within striking distance of 50-day average 10:22 a.m. Oct. 24, 2014 - Michael Ashbaugh
Broadly-based snapback strengthens bull case 10:10 a.m. Oct. 22, 2014 - Michael Ashbaugh
U.S. stocks jump; Nasdaq enjoys best day in 21 months 3:38 p.m. Oct. 21, 2014 - Anora Mahmudova
U.S. benchmarks hesitate at major resistance 9:26 a.m. Oct. 20, 2014 - Michael Ashbaugh
Charting a failed retest of the 200-day average 10:16 a.m. Oct. 15, 2014 - Michael Ashbaugh
Tekmira CEO says being a biotech is like being in ‘shark-infested water’ 7:03 a.m. Oct. 8, 2014 - Wallace Witkowski
Charting the October technical breakdown 10:06 a.m. Oct. 2, 2014 - Michael Ashbaugh
Charting the S&P 500’s precarious posture 9:44 a.m. Sept. 25, 2014 - Michael Ashbaugh
Nasdaq balks at the September peak 9:40 a.m. Sept. 22, 2014 - Michael Ashbaugh
U.S. stocks end lower; tech and small-caps lead losses 3:09 p.m. Sept. 15, 2014 - Anora Mahmudova
Stock-picking gains traction as volatility looms 5:01 a.m. Sept. 7, 2014 - Wallace Witkowski

Low-Volume Pullback Looks Like History Repeating 8:43 p.m. Dec. 30, 2014 - InvestorPlace.com
Healthcare Stocks Pause, Is Biotech Boom Over? 11:16 a.m. Dec. 30, 2014 - Barrons.com
DoctoRx Positions For 2015: I Have Cut Back On My Exposure To All Biotech Substantially 7:05 a.m. Dec. 30, 2014 - Seeking Alpha
Analyzing The First Trust Health Care AlphaDEX ETF: How Did It Do It? 11:40 a.m. Dec. 29, 2014 - Seeking Alpha
TherapeuticsMD Is a Top Stock Under $10 for 2015: David Peltier 10:35 a.m. Dec. 29, 2014 - TheStreet.com
Biotech Weekly: Charts And Themes Present Mildly Bullish Outlook Into 2015 8:13 a.m. Dec. 29, 2014 - Seeking Alpha
Market Makes New Highs, but Inconsistencies Are Troubling 8:20 p.m. Dec. 28, 2014 - InvestorPlace.com
Gilead, Abbvie, Express Scripts, And Biotech Industry Turmoil Seen By Market-Makers 9:33 a.m. Dec. 24, 2014 - Seeking Alpha
Why I Expect The Biotech Sell-Off To Continue Into 2015 8:08 a.m. Dec. 24, 2014 - Seeking Alpha
Cramer's Mad Money - Navigator Holdings Has Been Unfairly Punished (12/23/14) 5:37 a.m. Dec. 24, 2014 - Seeking Alpha
Bulls Rejoice Dow 18,000, but Maybe Not for Long 8:51 p.m. Dec. 23, 2014 - InvestorPlace.com
Jim Cramer's 'Mad Money' Recap: Here Are 10 Stocks to Buy on Strong GDP Data 8:26 p.m. Dec. 23, 2014 - TheStreet.com
Investors Should Stay Long Stocks as Market Continues Hitting Highs 3:01 p.m. Dec. 23, 2014 - TheStreet.com
Inside The 2 New Innovative Biotech ETFs From BioShares 3:00 p.m. Dec. 23, 2014 - Seeking Alpha
Gilead Falls on AbbVie and Express Scripts Deal: 3 Biotech ETFs to Watch - ETF News And Commentary 12:02 p.m. Dec. 23, 2014 - Zacks.com
Inside the Two New Innovative Biotech ETFs from BioShares - ETF News And Commentary 8:02 a.m. Dec. 23, 2014 - Zacks.com
Making Money With Charles Payne: 12/22/14 6:00 p.m. Dec. 22, 2014 - FOXBusiness
Abbvie Versus Gilead In Hepatitis C, With Comments On Biotech 2:09 p.m. Dec. 22, 2014 - Seeking Alpha
No Bargains in Rising Market: Why Not Buy High and Sell Higher? 12:29 p.m. Dec. 22, 2014 - TheStreet.com
Bioshares New Equal Weight ETFs Offer Diversification And Growth 11:01 a.m. Dec. 22, 2014 - Seeking Alpha

GW Pharmaceuticals Added to NASDAQ Biotechnology Index 2:00 a.m. Dec. 22, 2014 - GlobeNewswire
Hyperion Therapeutics Added to Nasdaq Biotechnology Index (NBI) 4:06 p.m. Dec. 18, 2014 - GlobeNewswire
Revance Therapeutics Added to NASDAQ Biotechnology Index 4:06 p.m. Dec. 18, 2014 - GlobeNewswire
Cara Therapeutics Announces Addition to the NASDAQ Biotechnology Index 8:01 a.m. Dec. 18, 2014 - GlobeNewswire
Relypsa to be Added to NASDAQ Biotechnology Index 8:01 a.m. Dec. 17, 2014 - GlobeNewswire
Alder BioPharmaceuticals Announces Addition to NASDAQ Biotechnology Index 4:02 p.m. Dec. 16, 2014 - GlobeNewswire
Kite Pharma Added to the NASDAQ Biotechnology Index 8:01 a.m. Dec. 16, 2014 - GlobeNewswire
Zafgen Added to NASDAQ Biotechnology Index 7:01 a.m. Dec. 16, 2014 - GlobeNewswire
Foundation Medicine to Be Added to NASDAQ Biotechnology Index 6:30 a.m. Dec. 16, 2014 - BusinessWire - BZX
Aerie Pharmaceuticals Added to NASDAQ Biotechnology Index (NBI) 6:30 a.m. Dec. 16, 2014 - BusinessWire - BZX
Cleveland Biolabs; A Diverse Play on Both Biodefense and Cancer 10:51 a.m. Nov. 13, 2014 - ACCESSWIRE
Premier Biomedical Advances Technology via Partnerships 9:29 a.m. May 9, 2014 - ACCESSWIRE
OxySure's Improving Financials & Operational Milestones Paint a Bullish Picture 8:01 a.m. March 10, 2014 - ACCESSWIRE
Regulus Announces Addition to NASDAQ Biotechnology Index 8:00 a.m. Dec. 23, 2013 - PR Newswire
Epizyme, Inc. to Be Added to NASDAQ Biotechnology Index (NBI) and NASDAQ Global Select Market 8:00 a.m. Dec. 20, 2013 - PR Newswire
KYTHERA Biopharmaceuticals Announces Addition to the NASDAQ Biotechnology Index 5:51 p.m. Dec. 19, 2013 - GlobeNewswire
Verastem Announces Addition to the NASDAQ Biotechnology Index 7:00 a.m. Dec. 19, 2013 - BusinessWire
Horizon Pharma to Be Added to NASDAQ Biotechnology Index 7:30 a.m. Dec. 17, 2013 - Marketwire
Chimerix Added to NASDAQ Biotechnology Index (NBI) 7:00 a.m. Dec. 17, 2013 - GlobeNewswire
Annual Changes to the NASDAQ Biotechnology Index 8:05 a.m. Dec. 16, 2013 - GlobeNewswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

RavenPack's Data Innovation: Sharpening Financial Analysis

Innovating Financial Analysis with AI They said AI would change everything, but who knew it'd make such a wave in turning research ideas into actionable datasets? RavenPack's latest maneuver is rewriting the playbook. By leveraging a fine-tuned NVIDIA Nemotron model, they've managed to label a mind-boggling 845,220 financial-text excerpts in under an hour. It's not just...

Sony's Game-Changing Sensor Reshapes Medical Endoscopy

In a world where medical tech innovation can make the difference between life and death, Sony’s latest feat will turn some heads in the healthcare industry. This ain’t about another PlayStation release; we’re talking the IMX742 CMOS image sensor crafted for single-use endoscopes. As far as breakthroughs go, the microscopic square sensor packs a surprising punch by...

Sony's IMX742: Revolutionizing Endoscopic Imaging

Sony's Bold Move into Medical Tech You wouldn't expect a company like Sony to make waves in the medical field, but there they go again, shaking things up with their latest announcement. Lurking past the shiny consumer electronics, they've got the IMX742, a sensor designed for single-use endoscopes. A humble 1 mm square powerhouse, boasting about 0.51 megapixels of digital...

EverSmith Rolls Out Training Hub to Propel Franchise Growth

Big Ambitions Nestled in Milford, Ohio Beneath the glow of fluorescent lights in a fresh-to-the-world 12,000-square-foot box of opportunity, EverSmith Brands is betting on big returns. EverHUB has opened its doors, aiming to be the cradle that hatches their aggressive franchise dreams into reality. It's not just brick and mortar—it’s the manifestation of their grand...

Trilogy Metals Advances Arctic Project's Potential

Trilogy Metals Completes Ambler Metals Field Work Alright, folks, let's dive into a mining story that should catch the discerning eye. Trilogy Metals (NYSE: TMQ) proudly wrapped up its 2026 field season at the Upper Kobuk Mineral Projects (UKMP), located in northwestern Alaska. And if you're neck-deep in the mining sector, this isn't just a thing on the periphery; it's a...

Chemours Investors Face Crucial Class Action Deadline

High Stakes for Chemours Shareholders Well, this isn’t your run-of-the-mill shareholder grumble. We're staring down an 18.63% plunge in Chemours’ stock—plenty to raise the eyebrows of anyone keeping tabs on this chemical giant. For those who snatched up Chemours shares between February 20 and August 4, 2026, the revelations about potential misstatements concerning...

St. Croix Financial Hub: Game Changer or Fluff?

You know, sometimes it feels like the financial world gets more tangled than a fishing line on a windy beach. This latest spiel coming out of St. Croix with all its big names and lofty promises—Governor Bryan’s 3rd Wall Street Financial District Hub Initiative—seems like one of those, but maybe it’s got more meat than hype. Half the pitch sounds like your typical...

PuroClean Shines in Franchise Rankings with Global Growth

Diversifying with Property Restoration Stroll through any franchise expo and the buzzwords are all there: growth, opportunity, scalability. But in the crowded room of glittery pitches, the ones really shaking things up are those that go beyond the razzle-dazzle—brands like PuroClean that stick it to the competition with real, boots-on-the-ground expansion. The...

Pearl Meyer Bolsters Leadership Team with Key Additions

In the fast-paced world of executive advising, Pearl Meyer just cranked up the heat, announcing the addition of four seasoned managing directors to their Leadership Advisory practice. These new folks are here to shake things up, with a strong focus on executive assessment, leadership effectiveness, and organizational transformation. Strategic Moves in Leadership Adding...

MIAX Launches New Fertilizer Futures Amid Market Fluctuations

MIAX Sets Sights on Fertilizer Futures Out of the blue, we’ve got MIAX—one of the major players in financial markets—tossing their hat into the ring with fertilizer futures. They aren’t just playing around; they’ve launched four new physically-settled fertilizer futures contracts. You might wonder, why fertilizers? Hang tight, I'll tell you. MIAX is tapping into...